Zydus Lifesciences Ltd. NSE: ZYDUSLIFE | BSE: 532321

Mid-range Performer

Download real time

967.65 -0.80 (-0.08%)

26.93% Fall from 52W High

583.0K

NSE+BSE Volume

NSE 15 Jul, 2025 3:31 PM (IST)

Dividend

Zydus Lifesciences Ltd. has an upcoming dividend of ₹11.00 per share due on 25 Jul 2025 See details

Zydus Lifesciences Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Zydus Lifesciences Ltd. from all sources in a single place.

Zydus Lifesciences Ltd.

15 Jul 2025, 03:47PM

967.65

-0.08%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200 mg and 400 mg.

Zydus Lifesciences Ltd.

12 Jul 2025

967.65

-0.08%

Company Update

Zydus Lifesciences Ltd - 532321 - Incorporation Of A WOS In The United States Of America

BSE India

Incorporation of a WOS in the United States of America

Zydus Lifesciences Ltd.

10 Jul 2025

967.65

-0.08%

Company Update

Zydus Lifesciences Ltd - 532321 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under regulation 74(5) of the SEBI (Depository and Participants) Regulations, 2018 for the quarter ended on June 30, 2025.

Zydus Lifesciences Ltd.

10 Jul 2025

967.65

-0.08%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper publication of Notice of loss of share certificate of the Company, published in Financial Express English and Gujarati Editions, both on July 10, 2025.

Zydus Lifesciences Ltd.

03 Jul 2025

967.65

-0.08%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper advertisement with regard to notice and information of 30th Annual General Meeting of the Company published in the Financial Express.

Zydus Lifesciences Ltd.

02 Jul 2025

967.65

-0.08%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper publication of notice of loss of share certificate of the Company, published in the Financial Express English and Gujarati editions, both on July 2, 2025.

Zydus Lifesciences Ltd.

01 Jul 2025

967.65

-0.08%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper advertisement published in the Financial Express English and Gujarati edition with regard to the Notice to the shareholders for claiming their shares which are proposed to be transferred to the Investor Education and Protection Fund.

Zydus Lifesciences Ltd.

27 Jun 2025

967.65

-0.08%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

BSE India

Update on subscription of equity shares of (i) Torrent Urja 25 Private Limited and (ii) Torrent Urja 26 Private Limited

Zydus Lifesciences Ltd.

27 Jun 2025

967.65

-0.08%

SAST

Zydus Lifesciences Ltd - 532321 - Closure of Trading Window

BSE India

Intimation of trading window closure

Zydus Lifesciences Ltd.

24 Jun 2025

967.65

-0.08%

Investor Presentation

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

The Investor presentation to be made during the investors'' conference to be held between June 25, 2025 to June 27, 2025.

Is Cadila Healthcare Ltd. worth buying?

851 Votes:

Buy 82.02%

Sell 9.87%

Hold 8.11%

RESEARCH REPORTS

Hold SEE REPORTS >

Accumulate SEE REPORTS >